Sort
25,944 grants matching “neurodegeneration”
Role of oligomeric alpha-synuclein in synucleinopathies
$386,642Pamela J McLean · Massachusetts General Hospital · R01 · FY2009 · NS
Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease
$386,628Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · AG
Structure-Function Relationships of Immunoreceptors
$386,598Barbara A Baird · Cornell University · R01 · FY2011 · AI
MODULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITY
$386,582Charles F Zorumski · Washington University · R01 · FY2013 · MH
Polyadenylation and Translational Control
$386,575Joel D Richter · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · GM
Polyadenylation and Translational Control
$386,575Joel D Richter · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · GM
Polyadenylation and Translational Control
$386,575Joel D Richter · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · GM
Cell Signaling and Neurodegeneration
$386,551Harry T. Orr · University Of Minnesota · R01 · FY2010 · NS
Structure-Function Relationships of Immunoreceptors
$386,510Barbara A Baird · Cornell University · R01 · FY2012 · AI
Oxidative stress and RNA methylation
$386,458Ricardo C Aguiar · University Of Texas Hlth Science Center · R01 · FY2021 · ES
Genetic analysis of UBQLN2-associated neurodegeneration in frontotemporal dementia
$386,449Randal Scot Tibbetts · University Of Wisconsin-Madison · R01 · FY2024 · AG
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degeneration
$386,445Philip Raymond Williams · Washington University · R01 · FY2023 · EY
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
$386,415Elliot J Androphy · Indiana University Indianapolis · R01 · FY2020 · NS
Chemoproteomic mapping of the ligandable ribonucleoproteome using phloroglucinol meroterpenoids
$386,397Mikail E Abbasov · Cornell University · R35 · FY2021 · GM
Understanding Cell-type Vulnerability and Oxidative Stress Pathology in Parkinson's Disease Using Isogenic Human Dopaminergic Neurons
$386,375Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS
Transcriptional Control of Microglia Diversification and Inflammation
$386,375Anne Schaefer · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
$386,340Mi-Hyeon Jang · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
$386,339Mi-Hyeon Jang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · CA
Mechanism of Gp1 mGluR-dependent translation and plasticity
$386,298Nien-Pei Tsai · University Of Illinois At Urbana-Champaign · R01 · FY2022 · MH
Project 4: A Developmental Perspective to Nitrosative/Oxidative Susceptibility
$386,294Evan Yale Snyder · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · ES
Molecular mechanisms of Progranulin in Neurodegeneration
$386,280Thomas L Kukar · Emory University · R01 · FY2019 · NS
Mechanisms of Selective Neurodegeneration in Parkinson Disease
$386,250Xugang Xia · Thomas Jefferson University · R01 · FY2010 · NS
Using NAD+ precursor for treatment of global cerebral ischemia
$386,250Tibor Kristian · University Of Maryland Baltimore · R01 · FY2021 · NS
Using NAD+ precursor for treatment of global cerebral ischemia
$386,250Tibor Kristian · University Of Maryland Baltimore · R01 · FY2025 · NS
SCA7 NEURODEGENERATION: MOLECULAR BASIS AND THERAPY
$386,250Albert R La Spada · University Of California, San Diego · R01 · FY2009 · EY